{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:03:03Z","timestamp":1751601783229,"version":"3.41.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The efficacy and safety of drug-coated balloons (DCBs) in the treatment of aortoiliac artery stenosis or occlusion remains poorly explored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A single-center retrospective cohort study of patients diagnosed with iliac artery stenosis or occlusion who received either iliac artery DCB angioplasty or stent implantation was conducted at our institution. The patients were followed up 6 and 12 months postoperatively. Lower limb computed tomography angiography was performed during the follow-up period. The primary endpoint of the study was the primary patency at 6 and 12 months. Both the clinical and follow-up data were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>50 patients underwent DCB angioplasty, while 71 received stent implantation. Demographic and lesion characteristics were comparable between the two groups (<jats:italic>P<\/jats:italic>\u2009&amp;gt;\u20090.05). However, the balloon diameter used in the DCB group was significantly smaller (6.42\u2009\u00b1\u20090.80\u2005mm vs. 7.39\u2009\u00b1\u20090.97\u2005mm, <jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001). The primary patency values 6 and 12 months postoperatively were 84.2% and 80.7% for the DCB group and 96.1% and 89.6% for the stent group, respectively with no significant difference between the two groups (<jats:italic>P<\/jats:italic>\u2009=\u20090.124). However, the 12-month patency in the common iliac artery segment for the DCB group was significantly lower than that for the stent group (75.0% vs. 97.3%, <jats:italic>P<\/jats:italic>\u2009=\u20090.006). Univariate and multivariate logistic analyses did not identify any factors associated with long-term patency.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Same as stents, DCBs maintained a favorable but lower patency rate across various calcification levels and different TASC \u2161 classification in patients with aortoiliac artery stenosis or occlusion.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fsurg.2025.1598354","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T06:09:17Z","timestamp":1751522957000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Early outcomes of drug-coated balloon angioplasty and stent placement for the treatment of iliac artery lesions"],"prefix":"10.3389","volume":"12","author":[{"given":"Jia-Hao","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/1526602817720463","article-title":"Pivotal study of a next-generation balloon-expandable stent-graft for treatment of iliac occlusive disease","volume":"24","author":"Bismuth","year":"2017","journal-title":"J Endovasc Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pcad.2021.02.010","article-title":"Aorto-iliac peripheral artery disease","volume":"65","author":"Javed","year":"2021","journal-title":"Prog Cardiovasc Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/1358863X15597877","article-title":"An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"5","author":"Committee","year":"2015","journal-title":"Vasc Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/1526602816643834","article-title":"Covered vs uncovered stents for aortoiliac and femoropopliteal arterial disease: a systematic review and meta-analysis","volume":"23","author":"Hajibandeh","year":"2016","journal-title":"J. Endovasc. Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jvir.2018.12.707","article-title":"Icast balloon-expandable covered stent for iliac artery lesions: 3-year results from the icarus multicenter study","volume":"30","author":"Laird","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jvir.2018.12.031","article-title":"Balloon-expandable vascular covered stent in the treatment of iliac artery occlusive disease: 9-month results from the bolster multicenter study","volume":"30","author":"Laird","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1177\/15385744211010381","article-title":"Covered stents for endovascular treatment of aortoiliac occlusive disease: a systematic review and meta-analysis","volume":"55","author":"Mallory","year":"2021","journal-title":"Vasc Endovasc Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00270-023-03370-9","article-title":"Outcomes of self-expanding covered stents for the treatment of external iliac artery obstructive disease","volume":"46","author":"Squizzato","year":"2023","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ejvs.2019.12.034","article-title":"Editor\u2019s choice\u2014long term survival after femoropopliteal artery revascularisation with paclitaxel coated devices: a propensity score matched cohort analysis","volume":"59","author":"Behrendt","year":"2020","journal-title":"Eur J Vasc Endovasc"},{"key":"B11","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/eurheartj\/ehac722","article-title":"Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis","volume":"44","author":"Koeckerling","year":"2023","journal-title":"Eur Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.avsg.2022.09.047","article-title":"Results of new dual-drug coated balloon angioplasty versus poba for femoropopliteal lesions","volume":"89","author":"Sallustro","year":"2023","journal-title":"Ann Vasc Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1177\/17085381231192731","article-title":"Endovascular treatment of re-stenotic iliac artery stents with drug-eluting balloons","volume":"32","author":"\u00d6zpak","year":"2023","journal-title":"Vascular"},{"key":"B14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/1526602815583851","article-title":"Drug-eluting vs standard balloon angioplasty for iliac stent restenosis: midterm results","volume":"22","author":"Stahlhoff","year":"2015","journal-title":"J Endovasc Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/ccd.28947","article-title":"Scai guidelines on device selection inaorto-iliac arterial interventions","volume":"96","author":"Feldman","year":"2020","journal-title":"Catheter Cardio Inte"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.jcin.2017.05.015","article-title":"Self-expanding versus balloon-expandable stents for iliac artery occlusive disease: the randomized ice trial","volume":"10","author":"Krankenberg","year":"2017","journal-title":"Jacc Cardiovasc Interv"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1366338","DOI":"10.3389\/fsurg.2024.1366338","article-title":"Outcomes of balloon angioplasty and stent placement for iliac artery lesions classified as TASC II a, b: a single-center study","volume":"11","author":"Duc Tin","year":"2024","journal-title":"Front Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"E212","DOI":"10.1002\/ccd.25387","article-title":"Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications","volume":"83","author":"Rocha-Singh","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.jacc.2020.02.010","article-title":"2020 AHA\/ACC key data elements and definitions for coronary revascularization: a report of the American College of Cardiology\/American Heart Association task force on clinical data standards (writing committee to develop clinical data standards for coronary revascularization)","volume":"75","author":"Dehmer","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/0003319717720052","article-title":"Endovascular treatment for steno-occlusive iliac artery disease: safety and long-term outcome","volume":"69","author":"M\u00fcller","year":"2018","journal-title":"Angiology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jvs.2015.04.450","article-title":"Lesion complexity drives the cost of superficial femoral artery endovascular interventions","volume":"62","author":"Walker","year":"2015","journal-title":"J. Vasc. Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/1526602817692960","article-title":"Results from the visibility iliac study: primary and cohort outcomes at 9 months","volume":"24","author":"Rundback","year":"2017","journal-title":"J Endovasc Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ejvs.2022.11.008","article-title":"Editor\u2019s choice\u2014two year results of the randomised discover trial comparing covered versus bare metal stents in the common iliac artery","volume":"65","author":"Bekken","year":"2023","journal-title":"Eur J Vasc Endovasc"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/j.jvs.2020.10.066","article-title":"Covered versus bare metal kissing stents for reconstruction of the aortic bifurcation in the iliacs registry","volume":"73","author":"Squizzato","year":"2021","journal-title":"J Vasc Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.jvs.2019.08.271","article-title":"The impact of female sex on the outcomes of endovascular treatment for iliac lesions","volume":"71","author":"Piazza","year":"2020","journal-title":"J Vasc Surg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12928-018-0525-x","article-title":"Iliac artery stent fracture associated with hip joint flexion","volume":"34","author":"Doi","year":"2019","journal-title":"Cardiovasc Interv Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jvs.2009.06.020","article-title":"Endovascular management of iliac rupture during endovascular aneurysm repair","volume":"50","author":"Fernandez","year":"2009","journal-title":"J Vasc Surg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jvs.2008.10.019","article-title":"Prevalence, factors, and clinical impact of self-expanding stent fractures following iliac artery stenting","volume":"49","author":"Higashiura","year":"2009","journal-title":"J Vasc Surg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5758\/vsi.230114","article-title":"Incidence and risk factors of iliac artery rupture during aortoiliac stenting","volume":"40","author":"Lee","year":"2024","journal-title":"Vasc Specialist Int"},{"key":"B30","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jvs.2025.04.025","article-title":"Mid-term outcomes of shockwave intravascular lithotripsy in the ivliac registry for the treatment of calcified iliac occlusive disease","author":"Fazzini","year":"2025","journal-title":"J Vasc Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/15266028221075563","article-title":"Intravascular lithotripsy and drug-coated balloon angioplasty for severely calcified femoropopliteal arterial disease","volume":"30","author":"Stavroulakis","year":"2023","journal-title":"J Endovasc Ther"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.carrev.2020.02.026","article-title":"Intravascular lithotripsy for treatment of calcified, stenotic iliac arteries: a cohort analysis from the disrupt pad iii study","volume":"21","author":"Armstrong","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.carrev.2020.06.015","article-title":"Shockwave\u2122 lithoplasty in combination with atherectomy in treating severe calcified femoropopliteal and iliac artery disease: a single-center experience","volume":"22","author":"Radaideh","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1177\/1526602819836749","article-title":"Rotational atherectomy plus drug-coated balloon angioplasty for the treatment of total in-stent occlusions in iliac and infrainguinal arteries","volume":"26","author":"Milnerowicz","year":"2019","journal-title":"J Endovasc Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ejvs.2021.10.035","article-title":"Efficacy and safety of intravascular lithotripsy in lower extremity peripheral artery disease: a systematic review and meta-analysis","volume":"63","author":"Wong","year":"2022","journal-title":"Eur J Vasc Endovasc"},{"key":"B36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.avsg.2023.01.043","article-title":"Primary drug-coated balloon versus drug-eluting stent for native atherosclerotic femoropopliteal lesions: a systematic review and meta-analysis","volume":"92","author":"Zenunaj","year":"2023","journal-title":"Ann Vasc Surg"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1598354\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T06:09:18Z","timestamp":1751522958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1598354\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":36,"alternative-id":["10.3389\/fsurg.2025.1598354"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2025.1598354","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}